Insiders who reported open-market trades in the last 12 months at the companies Jayson Rieger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Paul B. Manning - $17.51M in VRCA purchases and sales in the last 12 months
David Zawitz - $72K in VRCA purchases and sales in the last 12 months
Noah L. Rosenberg - $41K in VRCA purchases and sales in the last 12 months
John J. Kirby - $40K in VRCA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jayson Rieger is a corporate insider, tracked as CEO and President, Director of Verrica Pharmaceuticals Inc. (VRCA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jayson Rieger submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jayson Rieger been buying or selling stock?
Recorded transactions: 7 open-market purchases ($526K) and 0 open-market sales across all tracked filings.
Jayson Rieger is CEO and President, Director of Verrica Pharmaceuticals Inc. (VRCA). 5 SEC Form 4 filings on record going back to 2024, most recently on 18 August 2026. Most recent open-market trade: bought $25K of VRCA on 18 August 2026. Lifetime open-market purchases: $526K.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by Jayson Rieger.
InsiderAlpha's records for Jayson Rieger go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $175K (3 of 7 buys carry a usable dollar value, totaling $526K). The largest single buy on record is $400K of VRCA in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
